Concepedia

Tetsuro Otsuka

TO

6

Publications

345

Citations

6

H-Index

2019

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Showa University

Astellas Pharma (Netherlands)

Yokohama City University

Tetsuro Otsuka is an author at Astellas Pharma (Japan) specializing in hemodialysis, immunohematology, and clinical trials.

Top concepts

Publications per year

2019–2022

6

Publications

6

Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study

Tadao Akizawa, Tetsuro Otsuka, Michael Reusch et al. · Therapeutic Apheresis and Dialysis · 2019 · 103 citations · Full text

, , +21

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka et al. · Advances in Therapy · 2019 · 83 citations · Full text

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Tadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka et al. · ˜The œNephron journals/Nephron journals · 2020 · 63 citations · Full text

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD

Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka et al. · Kidney International Reports · 2021 · 62 citations · Full text

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients

Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka et al. · American Journal of Nephrology · 2021 · 23 citations · Full text

Rows per page

1–5 of 6